Skip to main content Back to Top
Advertisement

10/11/2019

Bisacodyl Suppositories

Products Affected - Description

    • Bisacodyl suppository, Major, 10 mg, 12 count, NDC 00904-6981-12
    • Bisacodyl suppository, Major, 10 mg, 100 count, NDC 00904-6981-60
    • Bisacodyl suppository, Rugby Laboratories, 10 mg, 12 count, NDC 00536-1355-12 - discontinued
    • Bisacodyl suppository, Rugby Laboratories, 10 mg, 100 count, NDC 00536-1238-01

Reason for the Shortage

    • G&W Laboratories discontinued bisacodyl suppositories.
    • Major has bisacodyl suppositories on shortage due to increased demand. Major updated their NDC numbers in September 2019.
    • Perrigo has bisacodyl suppositories available.
    • Rugby Laboratories has bisacodyl suppositories on shortage due to increased demand. Rugby updated their NDC numbers in September 2019.

Available Products

    • Bisacodyl suppository, Perrigo, 10 mg, 12 count, NDC 00574-7050-12
    • Bisacodyl suppository, Perrigo, 10 mg, 50 count, NDC 00574-7050-50

Estimated Resupply Dates

    • Major has bisacodyl 10 mg suppositories in 12 count and 100 count on back order and the company cannot estimate a release date.
    • Rugby Laboratories has bisacodyl 10 mg suppositories in 100 count on back order and the company cannot estimate a release date.

Updated

Updated October 11, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 16, 2019 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins